Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The Journal of Dermatological Treatment|July 6, 2026
Stapokibart provides significant improvements in signs and symptoms of atopic dermatitis irrespective of prior systemic treatment: a post-hoc analysis of a phase 3 trialYan Zhao, Litao Zhang, Liming Wu, et al.The British Journal of Dermatology|February 16, 2026
Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trialCheng Zhou, Yan Zhao, Guannan Zhu, et al.BMC Medicine|May 29, 2026
Anti-IL-4Rα antibody SHR-1819 for moderate-to-severe atopic dermatitis: a randomized phase 2 studyChaoying Gu, Huibin Yin, Bin Yang, et al.Photodiagnosis and Photodynamic Therapy|January 1, 2023
Clinical practice Guidelines for 5-Aminolevulinic acid photodynamic therapy for acne vulgaris in ChinaPeiru Wang, Bo Wang, Linglin Zhang, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|July 1, 2024
Efficacy and safety of topical minocycline foam (FMX101 4%) in treatment of Chinese subjects with moderate-to-severe facial acne vulgaris: A phase 3, multi-centre, randomized, double-blind, vehicle-controlled studyYan Le, Wenlin Yang, Jianyun Lu, et al.The Journal of Dermatological Treatment|July 15, 2026
Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trialsYan Zhao, Furen Zhang, Bin Yang, et al.Phenomics (Cham, Switzerland)|October 14, 2024
Expert Consensus on Big Data Collection of Skin and Appendage Disease Phenotypes in ChineseShuang Zhao, Zhongling Luo, Ying Wang, et al.Dermatitis : Contact, Atopic, Occupational, Drug|July 25, 2025
Efficacy and Safety of Extending Dosing Interval of Stapokibart in Patients with Atopic DermatitisYan Zhao, Cheng Zhou, Xiaoyong Man, et al.JAAD International|July 26, 2026
International expert consensus on transdermal drug delivery technologies in dermatologyJinjin Zhu, Yan Li, Xiuli Wang, et al.Frontiers in Immunology|June 25, 2026
SSGJ-608 in moderate-to-severe plaque psoriasis: a multicenter, randomized, open-label, phase 3 studyLin Cai, Jing Chen, Liming Wu, et al.Pageof 3